Skip to main content

How to Induce Arrhythmias with Orciprenaline

  • Chapter
  • First Online:
Arrhythmia Induction in the EP Lab
  • 849 Accesses

Abstract

Orciprenaline is a bronchodilator used for the treatment of asthma and COPD. The other name for orciprenaline is metaproterenol. It has a β2 selective effect with no effect on alpha receptors. It stimulates the smooth muscle in the bronchiole, uterus and arterioles supplying the skeletal muscle. Orciprenaline is a more specific β 2 agonist than isoproterenol hence causes less tachycardia and hypotension at equipotent doses.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hatch F, McKellop K, Hansen G, et al. Relative bioavailability of metaproterenol in humans utilizing a single dose stable isotope approach. J Pharm Sci. 1986;9:886–90.

    Article  Google Scholar 

  2. Rona G, Chappel C, Zsoter T, et al. Myocardial lesions circulatory and electrocardiographic changes produced by isoproterenol in the dog. Rev Can Biol. 1959;18:83–94.

    CAS  PubMed  Google Scholar 

  3. Hock C, Toh CCS, Khoo TH. Clinical trial of orciprenaline in bradyarrhythmias. Singapore Med J. 1975;16:100–5.

    Google Scholar 

  4. Parwani AS, Schroder A, Blaschke D, et al. Third- degree AV block sensitive to prednisolone 72 hour post ablation ov AVNRT. Clin Case Rep. 2017;5:671–4.

    Article  Google Scholar 

  5. Strohmer B, Hwang C. Ablation of postinfarction ventricular tachycardia guided by isolated diastolic potentials. Europace. 2003;5:375–80.

    Article  CAS  Google Scholar 

  6. Sinkovec M, Vrecar I, Sustar M, Pernat A, Rakovec P, et al. Electrophysiological and clinical characteristics of atrioventricular nodal reentrant tachycardia and long-term success of radiofrequency catheter ablation. Zdravniški vestnik. 2010;79:280–9.

    Google Scholar 

  7. Abd Al-Hassan A. Radiofrequency ablation of typical atrioventricular node reentry tachycardia in dual and multiple AV nodal pathways. Med J Babylon. 2015;3:745–54.

    Google Scholar 

  8. Weismuller P, Kuly S, Brandts B, et al. Is electrical stimulation during administration of catecholamines required for evaluation of success after ablation of atrioventricular node reentrant tachycardia? J Am Coll Cardiol. 2002;39:691–4.

    Article  Google Scholar 

  9. Shanks RG, Brick I, Hutchinson K, Roddie IC. Stimulation of adrenergic beta-receptors by orciprenaline. Br Med J. 1967;1:610.

    Article  CAS  Google Scholar 

  10. Rona G, Chapel C, Balazs T. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the dog. Rev Can Biol. 1959;18:83.

    CAS  PubMed  Google Scholar 

  11. Komadina KH, Carlson TA, Strollo PJ, et al. Electrophysiologic study of the effects of aminophylline and metaproterenol on canine myocardium. Chest. 1992;100:232–8.

    Article  Google Scholar 

  12. Kirchhof P, Klimas J, Fabritz L, et al. Stress and high heart rate provoke ventricular tachycardia in mice expressing triadin. J Mol Cell Cardiol. 2007;42:962–71.

    Article  CAS  Google Scholar 

  13. Gattiker R, Schmid E. Hemodynamic effects of dopamine, epinephrine and orciprenaline (Alupent) in patients early after cardiac surgery. Intensive Care Med. 1978;4:55–61.

    Article  CAS  Google Scholar 

  14. Pott C, Wegner F, Bogeholz N, Fischer A, et al. Supraventricular extrasystole due to 1:2 atrioventricular conduction: procedural characteristics and long term follow-up of slow pathway modulation. Eur Heart J. 2013;34(suppl 1_1):P2350.

    Article  Google Scholar 

  15. Weber HP, Kaltenbrunner W, Heinze A, et al. Laser catheter coagulation of atrial myocardium for ablation of atrioventricular node reentrant tachycardia. Eur Heart J. 1997;18:487–95.

    Article  CAS  Google Scholar 

  16. Heinroth KM, Kattenbeck K, Sabenow I. Multiple AV nodal pathways in patients with AV nodal reentrant tachycardia-more common than expected ? Europace. 2002;4:375–82.

    Article  CAS  Google Scholar 

  17. Reents T, Springer B, Hessling G, et al. Long-term follow-up after cryoablation for adolescent atrioventricular nodal reentrant tachycardia: recurrence is not predictable. Europace. 2012;14:1629–33.

    Article  Google Scholar 

  18. Wojdyla-Hordynska A, Kowalsi O, Hordynski G, et al. The effect of radiofrequency catheter ablation of frequent premature ventricular complexes and arrhythmia burden on left ventricular function. Kardiol Pol. 2017;75:698–704.

    Article  Google Scholar 

  19. Frey B, Kreiner G, Fitsch S, Veit S, Gossinger HD. Successful treatment of idiopathic left ventricular outflow tract tachycardia by catheter ablation or minimally invasive surgical cryoablation. PACE. 2000;23:870–6.

    Article  CAS  Google Scholar 

  20. Brunelli M, Raffa S, Grobe A. Residual condution after pulmonary vein isolation with a circular multielectrode radiofrequency catheter ablation: the role of adenosine and orciprenaline during a prolonged observation time. Int J Cardiol. 2013;168:4122–31.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

El Kamar, N., Naouar, L. (2019). How to Induce Arrhythmias with Orciprenaline. In: Cismaru, G. (eds) Arrhythmia Induction in the EP Lab. Springer, Cham. https://doi.org/10.1007/978-3-319-92729-9_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-92729-9_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-92728-2

  • Online ISBN: 978-3-319-92729-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics